Steven Marotta
Stock Analyst at CL King
(0.58)
# 3,738
Out of 4,789 analysts
15
Total ratings
37.5%
Success rate
-15.08%
Average return
Main Sectors:
Stocks Rated by Steven Marotta
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GIII G-III Apparel Group | Downgrades: Neutral | n/a | $27.47 | - | 1 | Dec 1, 2022 | |
| SHOO Steven Madden | Upgrades: Buy | n/a | $27.42 | - | 1 | Sep 28, 2022 | |
| CTKB Cytek Biosciences | Initiates: Overweight | $28 | $3.92 | +614.29% | 1 | Aug 17, 2021 | |
| AVTR Avantor | Upgrades: Overweight | $32 → $41 | $15.80 | +159.49% | 3 | Aug 2, 2021 | |
| CAL Caleres | Upgrades: Buy | $29 | $17.71 | +63.75% | 2 | Jun 1, 2021 | |
| CROX Crocs | Downgrades: Neutral | n/a | $109.14 | - | 3 | Jul 17, 2020 | |
| GCO Genesco | Upgrades: Buy | n/a | $21.78 | - | 4 | Jan 21, 2020 |
G-III Apparel Group
Dec 1, 2022
Downgrades: Neutral
Price Target: n/a
Current: $27.47
Upside: -
Steven Madden
Sep 28, 2022
Upgrades: Buy
Price Target: n/a
Current: $27.42
Upside: -
Cytek Biosciences
Aug 17, 2021
Initiates: Overweight
Price Target: $28
Current: $3.92
Upside: +614.29%
Avantor
Aug 2, 2021
Upgrades: Overweight
Price Target: $32 → $41
Current: $15.80
Upside: +159.49%
Caleres
Jun 1, 2021
Upgrades: Buy
Price Target: $29
Current: $17.71
Upside: +63.75%
Crocs
Jul 17, 2020
Downgrades: Neutral
Price Target: n/a
Current: $109.14
Upside: -
Genesco
Jan 21, 2020
Upgrades: Buy
Price Target: n/a
Current: $21.78
Upside: -